Second Annual University of Chicago Multidisciplinary Breast Cancer Symposium
UChicago Medicine
Updates in HR+/HER2- eBC: Choice of Chemotherapy, Adjuvant CDK4/6i
FEATURING
Nan Chen
- 186 views
- February 28, 2025
- 3
UChicago Medicine
Novel Therapeutic Strategies in Metastatic HR+/HER2- BC
FEATURING
Nan Chen
- 74 views
- February 28, 2025
UChicago Medicine
2025 Updates in HER2+ eBC: Neoadjuvant Therapy, De-Escalation With Imaging
FEATURING
Sudha Yarlagadda
- 33 views
- February 28, 2025
UChicago Medicine
2025 Updates in HER2+ mBC: Frontline Therapy, CNS Metastasis Management
FEATURING
Sudha Yarlagadda
- 60 views
- February 28, 2025
- 1
UChicago Medicine
Survivorship in Breast Cancer: Managing Long-Term Toxicities and Recurrence Risk
FEATURING
Maryam Lustberg
- 20 views
- February 28, 2025
UChicago Medicine
Radiation Therapy for Breast Cancer: The State-of-the-Art in 2025
FEATURING
Rohan Katipally
- 48 views
- February 28, 2025
UChicago Medicine
De-Escalating Axillary Surgery in eBC
FEATURING
Sarah Shubeck
- 11 views
- February 28, 2025
UChicago Medicine
Advancements in Breast Reconstruction and Lymphedema Prevention Therapies
FEATURING
Maureen Beederman
- 4 views
- February 28, 2025
UChicago Medicine
Ribociclib vs. Abemaciclib in Adjuvant eBC Setting
FEATURING
Maryam Lustberg,
Summer Hanson,
Sudha Yarlagadda,
Scott Grumeretz,
Donna Christian,
Heng Yang,
Joly Raju,
Amanda Krug
- 37 views
- February 28, 2025
UChicago Medicine
45 y/o Patient With Invasive Ductal Carcinoma Who Developed Bone Mets: Managing Toxicities
FEATURING
Maryam Lustberg,
Summer Hanson,
Sudha Yarlagadda,
Scott Grumeretz,
Donna Christian,
Heng Yang,
Joly Raju,
Amanda Krug
- 78 views
- February 28, 2025